Prostate Cancer Reports
54

Volume 5 Supplement 11
November 2017

.

Home > Prostate Cancer Reports > Volume 5, Year 2017 > Supplement 11, November




SPECIAL ISSUE ON SALVAGE RADIOTHERAPY AFTER RADICAL PROSTATECTOMY

CONTENTS



DIAGNOSIS
PROGNOSIS
TREATMENT



DIAGNOSIS



Eiber M, Maurer T, Souvatzoglou M, Beer AJ, Ruffani A, Haller B, Graner FP, Kübler H, Haberhorn U, Eisenhut M, Wester HJ, Gschwend JE, Schwaiger M.
Evaluation of Hybrid ⁶⁸Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy.
J Nucl Med. 2015 May;56(5):668-74. doi: 10.2967/jnumed.115.154153. Epub 2015 Mar 19.
Source | Abstract | Full text | Similar articles




Jadvar H.
PSMA PET in Prostate Cancer.
J Nucl Med. 2015 Aug;56(8):1131-2. doi: 10.2967/jnumed.115.157339. Epub 2015 May 14.
Comment on: Eiber M et al., Evaluation of Hybrid ⁶⁸Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy.
Source | Abstract | Full text | Similar articles




Raskolnikov D, George AK, Rais-Bahrami S, Turkbey B, Siddiqui MM, Shakir NA, Okoro C, Rothwax JT, Walton-Diaz A, Sankineni S, Su D, Stamatakis L, Merino MJ, Choyke PL, Wood BJ, Pinto PA.
The Role of Magnetic Resonance Image Guided Prostate Biopsy in Stratifying Men for Risk of Extracapsular Extension at Radical Prostatectomy.
J Urol. 2015 Jul;194(1):105-111. doi: 10.1016/j.juro.2015.01.072. Epub 2015 Jan 23.
Source | Abstract | Full text | Similar articles



PROGNOSIS



Briganti A, Karnes RJ, Joniau S, Boorjian SA, Cozzarini C, Gandaglia G, Hinkelbein W, Haustermans K, Tombal B, Shariat S, Sun M, Karakiewicz PI, Montorsi F, Van Poppel H, Wiegel T.
Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy.
Eur Urol. 2014 Sep;66(3):479-86. doi: 10.1016/j.eururo.2013.11.045. Epub 2013 Dec 12.
Source | Abstract | Full text | Similar articles




Fossati N, Karnes RJ, Colicchia M, Boorjian SA, Bossi A, Seisen T, Di Muzio N, Cozzarini C, Noris Chiorda B, Fiorino C, Gandaglia G, Dell'Oglio P, Shariat SF, Goldner G, Joniau S, Battaglia A, Haustermans K, De Meerleer G, Fonteyne V, Ost P, Van Poppel H, Wiegel T, Montorsi F, Briganti A.
Impact of Early Salvage Radiation Therapy in Patients with Persistently Elevated or Rising Prostate-specific Antigen After Radical Prostatectomy.
Eur Urol. 2017 Aug 2. pii: S0302-2838(17)30655-3. doi: 10.1016/j.eururo.2017.07.026. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Fossati N, Karnes JR, Morlacco A, Moschini M, Boorjian SA, Seisen T, Bossi A, Cozzarini C, Fiorino C, Chiorda BN, Gandaglia G, Tosco L, De Ridder D, Joniau S, Goldner G, Shariat SF, Hinkelbein W, Haustermans K, Tombal B, Montorsi F, Van Poppel H, Wiegel T, Briganti A.
MP14-11. When is the optimal timing for salvage radiation therapy in patients with increasing psa after radical prostatectomy? A patient risk stratification model based on prostate cancer aggressiveness.
J Urol. 2016 Apr. DOI: http://dx.doi.org/10.1016/j.juro.2016.02.2514
Source | Meeting Abstract | Full text | Similar srticles




Scher HI.
Management of prostate cancer after prostatectomy: treating the patient, not the PSA.
JAMA. 1999 May 5;281(17):1642-5.
Comment on: Pound CR et al, Natural history of progression after PSA elevation following radical prostatectomy. [JAMA. 1999]
Source | Abstract | Full text | Similar articles




Thoma C.
Prostate cancer: Stratifying salvage radiotherapy utility.
Nat Rev Urol. 2017 Aug 31. doi: 10.1038/nrurol.2017.145. [Epub ahead of print]
Comment on: Fossati N et al. (2017), Impact of Early Salvage Radiation Therapy in Patients with Persistently Elevated or Rising Prostate-specific Antigen After Radical Prostatectomy.
Source | Abstract | Full text | Similar articles




Zimmermann M, Delouya G, Alenizi AM, Rajih E, Zorn KC, Taussky D.
CAPRA-S predicts outcome for adjuvant and salvage external beam radiotherapy after radical prostatectomy.
Can Urol Assoc J. 2016 Mar-Apr;10(3-4):132-6. doi: 10.5489/cuaj.3365.
Source | Abstract | Full text | Similar articles



TREATMENT



Armstrong AJ, Halabi S, Healy P, Lee WR, Koontz BF, Moul JW, Mundy K, Creel P, Wood S, Davis K, Carducci MA, Stein M, Hobbs C, Reimer B, Nguyen M, Anand M, Bratt L, Kim S, Tran PT, George DJ; Department of Defense Prostate Cancer Clinical Trials Consortium.
A phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed by salvage radiation therapy in men with PSA recurrent prostate cancer after radical prostatectomy.
Prostate Cancer Prostatic Dis. 2016 Mar;19(1):100-6. doi: 10.1038/pcan.2015.59. Epub 2016 Jan 12.
Source | Abstract | Full text | Similar articles




Blumenthal-Barby JS, Lee D, Volk RJ.
Toward ethically responsible choice architecture in prostate cancer treatment decision-making.
CA Cancer J Clin. 2015 Jul-Aug;65(4):257-60. doi: 10.3322/caac.21283. Epub 2015 May 21.
Comment on:
Filson CP, Marks LS, Litwin MS. Expectant management for men with early stage prostate cancer
Violette PD, Agoritsas T, Alexander P, et al. Decision aids for localized prostate cancer treatment choice: systematic review and metaanalysis
Source | Abstract | Full text | Similar articles




Brunocilla E, Schiavina R, Nanni C, Borghesi M, Cevenini M, Molinaroli E, Vagnoni V, Castellucci P, Ceci F, Fanti S, Gaudiano C, Golfieri R, Martorana G.
First case of 18F-FACBC PET/CT-guided salvage radiotherapy for local relapse after radical prostatectomy with negative 11C-Choline PET/CT and multiparametric MRI: New imaging techniques may improve patient selection.
Arch Ital Urol Androl. 2014 Sep 30;86(3):239-40. doi: 10.4081/aiua.2014.3.239.
Source | Abstract | Full text | Similar articles




Carrie C, Hasbini A, de Laroche G, Richaud P, Guerif S, Latorzeff I, Supiot S, Bosset M, Lagrange JL, Beckendorf V, Lesaunier F, Dubray B, Wagner JP, N'Guyen TD, Suchaud JP, Créhange G, Barbier N, Habibian M, Ferlay C, Fourneret P, Ruffion A, Dussart S.
Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial.
Lancet Oncol. 2016 Jun;17(6):747-56. doi: 10.1016/S1470-2045(
16)00111-X. Epub 2016 May 6.
Source | Abstract | Full text | Similar articles




Carthon BC, Marcus DM, Herrel LA, Jani AB, Rossi PJ, Canter DJ.
Therapeutic options for a rising PSA after radical prostatectomy.
Can J Urol. 2013 Jun;20(3):6748-55.
Source | Abstract | Full text | Similar articles




Chien CP, Roach M 3rd.
Who, when, where, and how: salvage prostate cancer with radiotherapy.
Oncology (Williston Park). 2010 Jul;24(8):702, 704.
Comment on: Hamstra DA et al, Salvage external beam radiotherapy for prostate cancer after radical prostatectomy: current status and controversy. [Oncology (Williston Park). 2010]
Source | Abstract | Full text | Similar articles




Eifler JB, Smith JA Jr.
Chapter 49Management of PSA Recurrences After Radical Prostatectomy
Prostate Cancer (2nd Edition) Science and Clinical Practice, Academic Press 2016, 451–458 https://doi.org/10.1016/B978-0-12-800077-9.00049-9
Source | Abstract | Full text | Similar articles




Ervandian M, Høyer M, Petersen SE, Sengeløv L, Hansen S, Holmberg M, Sveistrup J, Meidahl Petersen P, Borre M.
Salvage radiation therapy following radical prostatectomy. A national Danish study.
Acta Oncol. 2016 May;55(5):598-603. doi: 10.3109/0284186X.2015.1088170. Epub 2015 Sep 23.
Source | Abstract | Full text | Similar articles




Gandaglia G, Briganti A, Clarke N, Karnes RJ, Graefen M, Ost P, Zietman AL, Roach M 3rd.
Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients.
Eur Urol. 2017 Nov;72(5):689-709. doi: 10.1016/j.eururo.2017.01.039. Epub 2017 Feb 8.
Source | Abstract | Full text | Similar articles




Gandaglia G, Cozzarini C, Mottrie A, Bossi A, Fossati N, Montorsi F, Briganti A.
The Role of Radiotherapy After Radical Prostatectomy in Patients with Prostate Cancer.
Curr Oncol Rep. 2015 Dec;17(12):53. doi: 10.1007/s11912-015-0478-5. Epub 2015 Oct 8.
Source | Abstract | Full text | Similar articles




Lacks C.
To Do Or Not Do: Radiation After a Radical Prostatectomy
Urol Res Found. quest_winter08_2. Accessed 2018 Feb 7.
Source | Abstract | Full text | Similar articles




Lin GA, Aaronson DS, Knight SJ, Carroll PR, Dudley RA.
Patient decision aids for prostate cancer treatment: a systematic review of the literature.
CA Cancer J Clin. 2009 Nov-Dec;59(6):379-90. doi: 10.3322/caac.20039. Epub 2009 Oct 19.
Source | Abstract | Full text | Similar articles




Nguyen PL, D'Amico AV.
Deciding which patients to treat with salvage radiotherapy after prostatectomy.
Oncology (Williston Park). 2010 Jul 22;24(8):705, 711.
Comment on: Hamstra DA et al, Salvage external beam radiotherapy for prostate cancer after radical prostatectomy: current status and controversy. [Oncology (Williston Park). 2010]
Source | Abstract | Full text | Similar articles




Parker CC, Sydes MR.
Postoperative radiotherapy after radical prostatectomy: let's work together to tackle the known unknowns.
Eur Urol. 2014 Jun;65(6):1044-5. doi: 10.1016/j.eururo.2013.09.035. Epub 2013 Sep 27.
Comment on: Pfister D et al, Early salvage radiotherapy following radical prostatectomy. [Eur Urol. 2014]
Source | Abstract | Full text | Similar articles




Pfister D, Bolla M, Briganti A, Carroll P, Cozzarini C, Joniau S, van Poppel H, Roach M, Stephenson A, Wiegel T, Zelefsky MJ.
Early salvage radiotherapy following radical prostatectomy.
Eur Urol. 2014 Jun;65(6):1034-43. doi: 10.1016/j.eururo.2013.08.013. Epub 2013 Aug 15.
Source | Abstract | Full text | Similar articles




Hamstra DA, Kim S, Yu JB.
Salvage external beam radiotherapy for prostate cancer after radical prostatectomy: current status and controversy.
Oncology (Williston Park). 2010 Jul 22;24(8):692-700, 702.
Source | Abstract | Full text | Similar articles




Selmaji IE, Udrescu C, Brahmi T, Samlali H, Lapierre A, Enachescu C, Ruffion A, Chapet O.
Salvage radiation therapy after radical prostatectomy: Contribution of a dose escalation to macroscopic local relapses.
J Clin Oncol. 2016 34:2_suppl, e634-e634. DOI: 10.1200/jco.2016.34.2_suppl.e634
Source | Meeting Abstract | Full text | Similar articles




Suleiman N, Yoshida K, Miyawaki D, Ejima Y, Nishimura H, Furukawa J, Fujisawa M, Sasaki R.
Efficacy of Salvage Radiation Therapy in Men With Biochemical Recurrence After Radical Prostatectomy: A Comparison With Endocrine Therapy
Int J Radiat Oncol Biol Phys. 2013 Oct 1; 87(s2),S366. DOI: http://dx.doi.org/10.1016/j.ijrobp.2013.06.962
Source | Meeting Abstract | Full text | Similar articles




Taguchi S, Shiraishi K, Fukuhara H, Nakagawa K, Morikawa T, Naito A, Kakutani S, Takeshima Y, Miyazaki H, Nakagawa T, Fujimura T, Kume H, Homma Y.
Optimal timing of salvage radiotherapy for biochemical recurrence after radical prostatectomy: is ultra-early salvage radiotherapy beneficial?
Radiat Oncol. 2016 Jul 30;11:102. doi: 10.1186/s13014-016-0671-1.
Source | Abstract | Full text | Similar articles




Violette PD, Agoritsas T, Alexander P, Riikonen J, Santti H, Agarwal A, Bhatnagar N, Dahm P, Montori V, Guyatt GH, Tikkinen KA.
Decision aids for localized prostate cancer treatment choice: Systematic review and meta-analysis.
CA Cancer J Clin. 2015 May-Jun;65(3):239-51. doi: 10.3322/caac.21272. Epub 2015 Mar 12.
Source | Abstract | Full text | Similar articles




Wahart A, Guy JB, Vallard A, Geissler B, Ben Mrad M, Falk AT, Prevot N, de Laroche G, Rancoule C, Chargari C, Magné N.
Intensity-modulated salvage radiotherapy with simultaneous integrated boost for local recurrence of prostate carcinoma: a pilot study on the place of PET-choline for guiding target volume delineation.
Br J Radiol. 2016;89(1058):20150579. doi: 10.1259/bjr.20150579. Epub 2015 Dec 9.
Source | Abstract | Full text | Similar articles




Walsh PC.
(In)-efficacy of salvage radiotherapy for rising PSA or clinically isolated local recurrence after radical prostatectomy.
J Urol. 2003 Apr;169(4):1596, 1597.
Source | Abstract | Full text | Similar articles